Consistent with past studies, the expression of IFIT1/2/3/5 was dysregulated in multiple types of human tumors, including bladder cancer, pancreatic cancer, oral squamous cell carcinoma and neck squamous cell carcinoma [26]. Here, IFIT1 is linked to pancreatic neoplasm.